drugset / Trial / NCT00432757

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

NCT00432757

Phase 3 Completed 120 enrolled Vistakon Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

Timeline

Start
2007-01
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketotifen Small molecule

Indications